Selegiline Treatment Facilitates Recovery After Stroke

Neurorehabilitation and Neural Repair

Volumn 15, Issue 3, 2001, Pages 183-190

  Sivenius, Juhani ^a   Sarasoja, Taneli ^a   Aaltonen, Helena ^b   Heinonen, Esa ^b   Kilkku, Olavi ^b   Reinikainen, Kari ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b ORION CORPORATION   (Finland)

Author keywords

Cerebrovascular disorders; L deprenyl; Recovery of function; Selegiline; Stroke

Indexed keywords

PLACEBO; SELEGILINE;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CEREBRAL ARTERY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE CEREBRAL ARTERY; PHASE 2 CLINICAL TRIAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STROKE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CEREBROVASCULAR ACCIDENT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; RECOVERY OF FUNCTION; SELEGILINE; TREATMENT OUTCOME;

EID: 0035734964     PISSN: 15459683     EISSN: None     Source Type: Journal    
DOI: 10.1177/154596830101500305     Document Type: Article

References (37)

1. Nakayama H., Jorgensen HS, Raschou H., et al Recovery of upper extremity function in stroke patients the Copenhagen Stroke Study Arch Phys Med Rehabil 1994, 75: 394-8
2. Feeney DM Mechanisms of noradreneregic modulation of physical therapy effects on functional recovery after cortical injury In. Godstein LB, ed Advances in pharmacotherapy for recovery after stroke Armont, NY Futura, 35-78
3. Sutton RL, Hovda DA, Feeney DM Amphetamine accelerates functional recovery following bilateral frontal cortex ablation in cat Behav Neurosci 1989, 8 37-41
4. Goldstein LB Effects of amphetamines and small related molecules on recovery after stroke in animals and man Neuropharmacology 2000, 39. 852-9
5. Walker-Batson D., Smith P., Curtis S., et al. Amphetamine paired with physical therapy accelerates motor recovery after stroke. further evidence Stroke 1995; 26: 2254-9
6. Oerthel WH, Quinn NP Parkinson's disease. drug therapy Bail-heres Clin Neurol 1997, 6. 89-108
7. Magyar KB, Szende J., Lengyel J., et al The neuroprotective and neuronal rescue effects of (-)-deprenyl. J Neural Transm 1998, 52(suppl) 109-23
8. Tatton WG Selegiline can mediate neuronal rescue rather than neuronal protection Mov Disord 1993, 8(suppl) S20-30
9. Knollema S., Aukema W., Hom H., et al L-deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia Stroke 1995, 26. 1883-7
10. Matsui Y., Kumagae Y. Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia Neurosci Lett 1991; 126 175-8.
11. Lahtinen J., Koistmaho J., Kauppinen R., et al Selegiline treatment after transient global ischemia in gerbils enhances the survival of CA1 pyramidal cells in the hippocampus Brain Res 1997; 757 260-7.
12. Paterson IA, Barber AJ, Gelowitz DL, et al Deprenyl reduces delayed neuronal death of hippocampal pyramidal cells. Neurosci Biobehav Rev 1997; 21 181-6.
13. Semkova I., Wolz P., Schilling M., et al. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage Eur J Pharmacol 1996, 315. 19-30
14. Biagini G., Frasoldati A., Fuxe K., et al. The concept of astrocyte-kinetic drug in the treatment of neurodegenerative diseases evidence for L-deprenyl-induced activation of reactive astrocytes Neurochem Int 1994, 25: 17-22.
15. Riva MA, Molteni R., Racgni G. L-deprenyl potentiates cAMPmduced of FGF-2 mRNA levels in rat cortical astrocytes Neuroreport 1997, 8. 2165-8
16. Tang YP, Ma YL, Chao CC, et al Enhanced glial cell line-derived neurotrophic factor mRNA expression upon (-)-deprenyl and melatonin treatments J Neurosci Res 1998; 53 593-604
17. Lessman V. Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS Gen Pharmacol 1998, 31: 667-74
18. Schuman EM Neurotrophin regulation of synaptic transmission Curr Opin Neurobiol 1999; 9: 105-9.
19. Boulanger L., Poo MM Presynaptic depolarization facilitates neurotrophin-induced synaptic potentiation Nat Neurosci 1999, 2 346-51
20. Caleo M., Lodovichi C., Maffei L. Effects of nerve growth factor on visual cortical plasticity require afferent electrical activity. Eur J Neurosci 1999, 11 2979-84
21. Kuhmonen J., Jolkkonen J., Haapalmna A., et al The neuroprotective effects of deprenyl m the gerbil hippocampus following transient global ischemia J Neural Transm 2000, 107 779-86
22. Scandinavian Stroke Study Group Multicenter trial of hemodilution m ischemic stroke. background and study protocol Stroke 1985, 16. 885-90
23. Scandinavian Stroke Study Group Multicenter trial of hemodilution m ischemic stroke Stroke 1987, 18. 691-9
24. Shah S., Vanclay F., Cooper D. Improving the sensitivity of the Barthel index for stroke rehabilitation J Clin Epidemiol 1989, 42 703-9
25. Lindenstr⊘m E., Boysen G., Christiansen LW, et al. Reliability of Scandinavian Neurological Stroke Scale. Cerebrovasc Dis 1991, 1. 103-7
26. Mahoney FI, Barthel DW Functional evaluation the Barthel index Annual Meeting-April. 21, 22, 1965,23:61-5
27. Fugl-Meyer A., Jaasko L. Leyman I. The post stroke hemiplegic patient a method of evaluation of physical performance. Scand Rehabil Med 1975, 7 13-31.
28. Sintonen H., Pekurinen M. 15D-askel kohti yleista terveyteen liittyvan elamanlaadun mittaria Sos laaketieteen Aikakauslehti 1989, 26 85-95
29. Zung Wwk A self rating depression scale Arch Gen Psychiatry 1965, 12. 63-70.
30. Grade C., Redford B., Chrostowski J., et al Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study Arch Phys Med Rehabil 1998, 79 1047-50
31. Biel JH, Bopp BA Amphetamines structure-activity relationships In Iverson L, Synder S, eds Handbook of psychopharmacology. Vol II New York Plenum Press, 1979. 131.
32. del Zoppo GJ, Wagner S., Tagaya M. Trends and future developments m the pharmacological treatment of acute ischemic stroke. Drugs 1997, 54. 9-38
33. Christou I., Alexandrov AV, Burgm WS, et al. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke Stroke 2000; 31 1812-6.
34. Puurunen K., Jolkkonen J., Sirvio J., et al Selegiline combined with enriched-environment housing attenuates spatial learning deficits following focal cerebral ischemia in rats Exp Neurol 2001, 167 348-55
35. Feeney DM, Gonzales A., Law WA Amphetamine, halopendol, and experience interact to affect rate of recovery after motor cortex injury Science 1982, 217 855-7
36. Feeney DM, Hovda DA Reinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablation Brain Res 1985,342. 352-6
37. Puurunen K., Jolkkonen J., Sirvio J., et al An α2-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia m rats Neuropharmacology 2001; 40: 597-606